Dawn Health is a Danish IT consultancy company specialized in digitalization of the global life science industry.
Focusing on regulated digital healthcare solutions – Software as a Medical Device (SaMD) and Digital Therapeutics (DTx) – Dawn Health contributes to the existing health care industry with innovative health applications. The company’s mission is to develop healthcare solutions with the ultimate vision to help people live longer, healthier, and better lives.
Dawn Health seeks to democratize access and insight to healthcare data with a digital and cloud-based platform. The platform enables more effective development of healthcare applications, directed towards patients and healthcare professionals, on the behalf of Life Science companies. The benefits hereof include improved assessments and planning of treatments for patients with chronic diseases.
Dawn Health is headquartered in Copenhagen and was founded in 2016 by Daniel Daugaard. Today, the company delivers digital healthcare solutions to large international Life Science companies including Novo Nordisk, Pfizer, Takeda, Coloplast and many more. Chr. Augustinus Fabrikker invested in Dawn Health in November 2021.